The connection of anal and cervical HPV infection in high risk women

Czech version

Authors: Borek Sehnal ¹; Michael Halaška ¹; Daniel Driák ¹; Jiří Sláma ²
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a Nemocnice Na Bulovce, přednosta prof. MUDr. Michael Halaška, DrSc. ¹; Onkogynekologické centrum, Gynekologicko-porodnická klinika 1. LF UK a VFN, přednosta prof. MUDr. Alois Martan, DrSc. ²
Published in: Prakt Gyn 2014; 18(1): 60-63
Category: Oncogynecology: Original Article

Overview

The infection by human papillomavirus (HPV) causes the development of several cancers. More than 99% of the cervical cancers and 90% of the anal cancers are associated with HPV infection. There is some connection between the cervical and anal HPV infections. Women with cervical HPV infection, cervical dysplasia and cervical cancer, are at increased risk for the anal infection and the anal cancer. According to the results of our study, the prevalence of anal HPV infection significantly increases with the severity of cervical lesion. Concurrent cervical-anal infection was observed in nearly half of women with severe cervical intraepithelial neoplasia and microinvasive cervical cancer. It was more than 5-fold more frequent than in the control group.

Key words:
anal cancer – anal HPV infection – cervical HPV infection – human papillomavirus

Sources

1. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine 2006; 24(Suppl 3): S11-S25.

2. Spitzer M. Human papillomavirus: epidemiology, natural history, and clinical sequelae. OBG Management 2006; 18(Suppl 2): S5-S10.

3. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003; 22(33): 5201–5207.

4. Viscidi RP, Schiffman M, Hildesheim A et al. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004; 13(2): 324–327.

5. Carter JJ, Koutsky LA, Hughes JP et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181(6): 1911–1919.

6. Schwarz TF. ASO4-adjuvanted human papillomavirus – 16/18 vaccination: recent advances in cervical cancer prevention. Expert Rev Vaccines 2008; 7(10): 1465–1473.

7. De Vuyst H, Clifford GM, Nascimento MC et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124(7): 1626–1636.

8. Tjalma WA, Fiander A, Reich O et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int. J. Cancer 2013; 132(4): 854–867.

9. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23: 15–20.

10. Palefsky JM, Holly EA, Ralston ML et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183(3): 383–391.

11. Goodman MT, Shvetsov YB, McDuffie K et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010; 201(9): 1331–1339.

12. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(Suppl 1): S1-S15.

13. Daling JR, Sherman KJ, Hislop TG et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135(2): 180–189.

14. Shvetsov YB, Hernandez BY, McDuffie K et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis 2009; 48(5): 536–546.

15. Winer RL, Lee SK, Hughes JP et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157(3): 218–226.

16. Scholefield JH, Hickson WG, Smith JH et al. Anal intraepithelial neoplasia: part of a multifocal disease proces. Lancet 1992; 340(8830): 1271–1273.

17. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40(4): 451–455.

18. Systém pro vizualizaci onkologických dat. Institut biostatistiky a analýz Lékařské a Přírodovědecké fakulty Masarykovy univerzity (IBA MU). Dostupné z WWW: <http://www.svod.cz>.

19. Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol 2007; 8(4): 311–316.

20. Parka IU, Ogilvie JW Jr, Andersonc KE et al. Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009; 114(3): 399–403.

21. Sehnal B, Dušek L, Cibula D et al. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. J Clin Virol 2014; 59(1): 18–23. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jcv.2013.11.004>.